Publisher
Springer Nature Singapore
Reference14 articles.
1. Wald NJ, Hackshaw AK, Walters J, Mackinson AM, Rodeck C, Chitty L. First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J Med Screen. 2003;10(2):56–104.
2. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med. 1999;341(7):461–7.
3. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet Gynecol. 2020;136(4):e48–69.
4. Benn PA, Campbell WA, Zelop CM, Ingardia C, Egan JF. Stepwise sequential screening for fetal aneuploidy. Am J Obstet Gynecol. 2007;197(3):312.e1–5.
5. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. Contingent screening for down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn. 2004;24(10):762–6.